Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Jazz Pharmaceuticals plcJAZZ · Entity 818 | Director | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Jazz Pharmaceuticals plc
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 6,452 |
Ending reported balance
After 2026-08-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-31 · Tax withholding · Disposed 15 · Balance 8,292 F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Row 2 · 2026-08-31 · Tax withholding · Disposed 1,840 · Balance 6,452 F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 21:09 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,840 | $241.39 | $444,157.60 |
DisclosureSEC source: 0002013944-26-000006 · edgardoc.xml · nonDerivative · entry 2 Kennedy Patrick · CIK 0002013944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,452 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 21:09 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 15 | $244.06 | $3,660.97 |
DisclosureSEC source: 0002013944-26-000006 · edgardoc.xml · nonDerivative · entry 1 Kennedy Patrick · CIK 0002013944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,292 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 21:48 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 1,605 | $0.00 | $0.00 |
DisclosureSEC source: 0002013944-26-000003 · edgardoc.xml · nonDerivative · entry 1 Kennedy Patrick · CIK 0002013944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,307 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027. Read SEC document |
| August 08, 2025 Filed Aug 11, 2025 21:42 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,959 | $111.25 | $217,939.93 |
DisclosureSEC source: 0001765581-25-000088 · edgardoc.xml · nonDerivative · entry 2 Kennedy Patrick · CIK 0002013944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,702 F2 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| August 07, 2025 Filed Aug 11, 2025 21:42 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000088 · edgardoc.xml · nonDerivative · entry 1 Kennedy Patrick · CIK 0002013944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,661 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 20:50 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 3,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-24-000068 · edgardoc.xml · nonDerivative · entry 1 Kennedy Patrick · CIK 0002013944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,154 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:32 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantCommon Stock | 1,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-24-000011 · edgardoc.xml · nonDerivative · entry 1 Kennedy Patrick · CIK 0002013944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,423 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.